Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32)-Reference-Cited by-同舟云学术

Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32)

Published:2023-05-09 Issue:1 Volume:200 Page:93-102
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Hershman Dawn L.^ORCID,Chen Bingshu E.,Sathe Claire,Parulekar Wendy R.,Lemieux Julie,Ligibel Jennifer A.,Gelmon Karen A.,Whelan Timothy J.,Goodwin Pamela J.

Funder

Canadian Cancer Society Research Institute

Division of Cancer Prevention, National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-023-06922-2.pdf

Reference20 articles.

1. Early Breast Cancer Trialists' Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–1717.

2. Winer EP, Hudis C, Burstein HJ et al (2005) American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 23(3):619–629

3. Hershman DL, Kushi LH, Shao T et al (2010) Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 28(27):4120–4128

4. Chirgwin JH, Giobbie-Hurder A, Coates AS et al (2016) Treatment adherence and its impact on disease-free survival in the breast international group 1–98 trial of tamoxifen and letrozole, alone and in sequence. J Clin Oncol 34(21):2452–2459

5. Paranjpe R, John G, Trivedi M, Abughosh S (2019) Identifying adherence barriers to oral endocrine therapy among breast cancer survivors. Breast Cancer Res Treat 174(2):297–305

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis;BMC Cancer;2024-06-06

2. Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs;Pharmaceutics;2023-08-24